AAT Bioquest, Inc. – Trademark Portfolio

Entity Type: 03

AAT Bioquest, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include FLUO-8, IFLUOR, AMPLITE, CAL-520, and CYTOTELL. The owner is based in Sunnyvale, CA.

520 Mercury Drive

Sunnyvale, CA 94085

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AAT Bioquest, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (8 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does AAT Bioquest, Inc. have?

AAT Bioquest, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 abandoned.

What trademark classes does AAT Bioquest, Inc. file in?

AAT Bioquest, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are AAT Bioquest, Inc.'s most well-known trademarks?

AAT Bioquest, Inc.'s registered trademark portfolio includes well-known marks such as FLUO-8, IFLUOR, AMPLITE, CAL-520, and CYTOTELL. These are among 8 currently registered trademarks in the portfolio.

What is AAT Bioquest, Inc.'s trademark registration success rate?

AAT Bioquest, Inc. has a 89% trademark registration rate, with 8 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.